How common is hematuria (presence of blood in the urine) in patients with sickle cell disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hematuria in Sickle Cell Disease: Prevalence and Management

Hematuria is a common complication in patients with sickle cell disease, occurring frequently due to renal papillary necrosis and vaso-occlusive events in the renal medulla. The presence of blood in the urine can range from microscopic to severe gross hematuria requiring medical intervention.

Prevalence and Pathophysiology

  • Hematuria is a well-established complication in patients with sickle cell hemoglobinopathies, including both homozygous sickle cell disease (HbSS) and heterozygous sickle cell trait (HbAS) 1, 2.

  • The pathophysiology involves sickling of red blood cells in the renal medulla, where the unique countercurrent mechanism creates conditions prone to sickling, leading to vaso-occlusion and papillary necrosis 2, 3.

  • Hematuria can occur in both sickle cell disease and sickle cell trait, with the latter often having hematuria as the only clinical manifestation of sickling 3.

Clinical Presentation

  • Hematuria in sickle cell disease can present as:

    • Microscopic hematuria (detected only on urinalysis) 4
    • Gross hematuria (visible blood in urine) 5, 6
    • Protracted, severe hematuria that may persist for months in some cases 5
  • Hematuria is typically unilateral and may be the only consequence of sickling in patients with sickle cell trait 3.

  • In severe cases, massive gross hematuria can occur, requiring urgent intervention 6.

Diagnostic Approach

  • Medical diagnosis of sickle cell-induced hematuria should be based on:

    • Presence of sickle cell disease or trait confirmed by hemoglobinopathy screening 4
    • Positive urographic findings of papillary necrosis 2
    • Exclusion of other causes of hematuria 2
  • Imaging studies may be necessary to confirm the diagnosis and rule out other causes:

    • Ultrasound is the preferred initial imaging modality to assess kidney size and structure 4
    • Further imaging may be required in cases of persistent or severe hematuria 4

Management

  • Most episodes of hematuria in sickle cell disease are self-limiting and resolve with conservative management 1.

  • Conservative management includes:

    • Adequate hydration to maintain good urine flow 4
    • Avoidance of dehydration which can worsen sickling 4
    • Pain management if associated with painful crisis 4
  • For persistent or severe hematuria, several treatment options have been reported:

    • Multiple doses of 1-desamino-8-D-arginine vasopressin (DDAVP) infusion have shown dramatic response in some cases of protracted gross hematuria 5
    • Oral urea therapy has been reported to inhibit gelation of deoxygenated sickle hemoglobin and resolve hematuria within days 3
    • Endourological approaches using balloon ureteral catheters to tamponade bleeding papillae have been successful in cases of massive hematuria 6
  • Surgical interventions such as partial or total nephrectomy are rarely needed and should be considered only after failure of medical management 5, 1.

Prevention and Follow-up

  • Patients with sickle cell disease should be monitored regularly for renal complications, including hematuria 4.

  • Preventive measures include:

    • Maintaining adequate hydration 4
    • Avoiding conditions that promote sickling (dehydration, hypoxia, acidosis) 4
    • Regular follow-up with specialists as part of a multidisciplinary care approach 4
  • Patients should be educated about the possibility of hematuria and instructed to seek medical attention if it occurs, especially if gross hematuria is present 4.

Special Considerations

  • In patients undergoing surgery, the risk of hematuria and other sickle cell-related complications may increase due to factors such as dehydration, hypoxia, and acidosis 4.

  • Careful perioperative management is essential to minimize these risks, including:

    • Adequate hydration 4
    • Maintenance of oxygenation 4
    • Avoidance of hypothermia 4
    • Early mobilization postoperatively 4
  • Patients with sickle cell disease often have impaired urinary concentrating ability and are at risk of dehydration, which can worsen hematuria 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.